Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

1 clinical trials · Condition

Record	Firm	Date
A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression (NCT06939452)	Yongxu Jia	2023-06-07

Every clearance here is in the API, with alerts when new ones post.